PROMOTING ACCESS TO AFRICAN RESEARCH

African Journal of Biotechnology

Log in or Register to get access to full text downloads.

Remember me or Register



Increasing trend of metronidazole resistance in the treatment of Helicobacter pylori infection: A global challenge

N Buta, NF Tanih, RN Ndip

Abstract


Helicobacter pylori are gram negative spiral bacteria that colonize the human stomach. Infection with H. pylori is associated with chronic gastritis, peptic ulcer, gastric adenocarcinoma and gastric mucosaassociated
lymphoid tissue (MALT) lymphoma. Antibiotic resistance is an ever increasing problem with the treatment of most microbial infections including H. pylori; and has become a growing problem worldwide with the eradication of this organism. In recent years, several treatment regimens have been proposed for H. pylori eradication. However, the only conditions for which such treatment is strongly recommended on the basis of unequivocal supporting evidence are peptic ulcer disease and low grade
gastric MALT lymphoma. Success of antimicrobial regimens for H. pylori eradication depends on patient compliance and lack of antimicrobial resistance. Metronidazole (Mtz) containing regimens have been shown to limit effectiveness because of increasing prevalence of resistance to this drug. A high prevalence (> 90%) of Mtz resistance in H. pylori has been reported especially in developing countries. Mtz resistance may be mediated through an inability of Mtz-resistant strains to remove oxygen from the site of Mtz reduction, thereby preventing Mtz activation. This has been attributed to a mutation on the frxA and/or rdxA genes resulting in strains of the organism with defective nitro-reductases coded by
these genes. Infection by Mtz or amoxicillin resistant strains is an important factor leading to treatment failure; subjecting all H. pylori clinical isolates to susceptibility testing most especially to Mtz is recommended. If not possible, a program to survey the prevalence of resistance should be
implemented in a given area or population. This increasing emergence of antimicrobial resistance in H.pylori treatment posses serious public health problems and is therefore necessary that new drug regimens be examined.



http://dx.doi.org/10.5897/AJB2010.000-3015
AJOL African Journals Online